Entinostat Does Not Overcome Endocrine Resistance in Advanced Breast Cancer
Cancer Therapy Advisor,
Adding entinostat to exemestane did not improve survival in patients with endocrine-resistant, advanced breast cancer…
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
Overview of attention for article published in Journal of Clinical Oncology, August 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 137 Mendeley